Posts Tagged: validity
Judge Grants Reconsiders, Reinstates Validity of TRX Fitness Equipment Patent Claims
The resurrection of the ‘814 patent claims was of great importance to Fitness Anywhere because it covered a modification to the company’s fitness equipment that helped it …
The Evolution of Antibody Patents
As the pharmaceutical industry continues to shift toward biologic-based drugs, including monoclonal antibodies, protecting the underlying technology has been and continues to be a priority for companies. …
Apple to pay VirnetX $93.4 million in costs and interest for patent infringement
On Monday, September 25th, Zephyr Cove, NV-based patent owner VirnetX Holding Corporation filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) regarding an …
Are all U.S. Patent Claims Invalid?
Nobel Biocare Srvcs. AG v. Instradent USA, Inc. makes one wonder whether all U.S. patents are invalid, or will eventually become invalid. This case demonstrates that …
Federal Circuit Reverses and Remands Board Decision Upholding Patentability
In an appeal from an IPR in which the Board upheld the patentability of several patent claims, the Federal Circuit vacated the decision and remanded to the …
Why is PTAB spending precious resources killing good patents?
Patents that have withstood scrutiny in Article III federal courts are not bad patents, they are good patents, and they ought not to be struck down by …
Patent Killing Fields of the PTAB: Erasing Federal District Court Verdicts on Patent Validity
Supporters of the Patent Trial and Appeal Board (PTAB) continue to claim that the facts and figures showing the PTAB is overruling Article III federal district court …
PTAB Facts: An ugly picture of a tribunal run amok
69% of cases reaching a final decision by the PTAB have all claims invalidated. 82.5% of patents reviewed by PTAB in a final decision are found defective... As the …
Packet Intelligence patents see different infringement outcomes in separate Eastern Texas cases
A jury verdict recently entered in a patent infringement case in the Eastern District of Texas held that plaintiff Packet Intelligence, a patent owning entity headquartered in …
FatPipe heralds mixed claim finding at PTAB which leaves “signature claim” intact
On November 1st, a panel of administrative patent judges (APJs) at the Patent Trial and Appeal Board (PTAB) issued a final written decision which found that 11 claims …
Solicitor General Tells SCOTUS that Patents are Public Rights in Oil States Brief
The government’s brief argues that IPR proceedings at the PTAB are consistent with Article III because, in its view, patents are public rights and not private …
Double jeopardy at the PTAB forces Allergan and others to seek sovereign immunity defenses
The PTAB subjects all patent owners to double jeopardy, but the situation is particularly bad for pharmaceutical companies which already have to face a Congressionally-mandated validity review …
Eli Lilly patent covering Alimta lung cancer treatment upheld in final written decision from PTAB
On Thursday, October 5th, a final written decision issued by the Patent Trial and Appeal Board (PTAB) upheld a series of 22 claims from a patent owned by …
Patent settlement between AbbVie and Amgen delays Humira generic until 2023
On Thursday, September 28th, a judge in the District of Delaware entered an order stipulating dismissal in a patent infringement case brought by North Chicago-based pharmaceutical firm …
Allergan’s patent transaction with St. Regis Mohawks could presage more arbitrage patent transactions
News of the St. Regis patent transaction has sparked interest in others pursuing similar arbitrage arrangements that provide revenue streams to Native American tribes outside of gambling …
